Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:

About CorMedix

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers.  For more information visit: www.cormedix.com.

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
[email protected]
(617) 430-7576

You May Also Be Interested In

• Arbor Realty Trust, Inc. Announces Proposed Private Offering of Convertible Senior Notes due 2029
• Digital Realty Schedules Second Quarter 2026 Earnings Release and Conference Call
• Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026